Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intellia Therapeutics Inc buy Bank of America Co.

Intellia Therapeutics Inc
Start price
€12.81
27.10.25 / 50%
Target price
€25.78
27.10.26
Performance (%)
-20.06%
Price
€10.24
13.08.26
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.06%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Intellia Therapeutics Inc 4.918% 4.918%
iShares Core DAX® 0.881% 5.632%
iShares Nasdaq 100 2.390% 1.571%
iShares Nikkei 225® 4.269% 2.521%
iShares S&P 500 1.171% 2.545%

Comments by Bank_of_America_Co_ for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -20.06%
Target price 25.779
Change
Ends at 27.10.26

Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Bank of America Corporation from $36.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat

Bank of America Co. 
0
Report Share
27.10.25